UNSPSC 51393306: Difeterol

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A2P950OCL0. European Medicines Agency schedules Difeterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07125MIG. Difeterol generally arises in the molecular formula C25H29NO2.

UNSPSC 51393306 Difeterol is a Commodity code under which state and local governments procure naloxone and drug deactivation systems for community health and emergency response programs. The code captures pharmaceutical and medical countermeasures—specifically opioid antagonists and related harm-reduction equipment—that state and local health departments, county health systems, and public health authorities deploy to support overdose prevention and public health initiatives. Recent activity shows county-level health agencies soliciting these products through competitive bidding to support community health programs and quarterly operational needs.

Seminole County, Florida issued an IFB (IFB60459723LAS) posted June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023, at 2:00 pm. The procurement required vendors to submit electronic bids through the county's e-Procurement Portal with all shipping and delivery costs included, comply with drug-free workplace certification and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract award would be fixed-fee with an initial two-year term and one-year renewal option, subject to a three-month probationary termination period. FEMA funding was identified as a potential source, introducing additional federal compliance obligations including adherence to the Clean Air Act and Federal Water Pollution Control Act. No explicit set-aside designations for disadvantaged enterprises were stated.